Latest for Achondroplasia
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
More about Achondroplasia
Beyond short stature, achondroplasia causes significant medical complications that require lifelong monitoring. Foramen magnum stenosis (narrowing at the base of the skull) is a serious concern in infancy that can compress the brainstem and spinal cord. Spinal stenosis develops in most adults and is the leading cause of pain and disability. Sleep apnea from midface hypoplasia affects a large proportion of children and adults.
Keep reading about Achondroplasia
Hydrocephalus, recurrent ear infections, and obesity are additional concerns. In 2021, the FDA approved Voxzogo (vosoritide), a C-type natriuretic peptide analog developed by BioMarin that counteracts the overactive FGFR3 signaling to promote bone growth in children with open growth plates. This was the first drug approved specifically for achondroplasia.
What are the symptoms of Achondroplasia?
These are common symptoms of Achondroplasia, and how strong they are varies from person to person.
- Short stature with disproportionately short arms and legs, especially upper arms and thighs
- Large head (macrocephaly) with prominent forehead and flattened nasal bridge
- Limited elbow extension and reduced range of motion at multiple joints
- Bowed legs (genu varum) that worsen with walking
- Exaggerated lower back curve (lumbar lordosis) with prominent abdomen
- Spinal stenosis causing back pain, leg weakness, and numbness in adulthood
- Obstructive sleep apnea from midface underdevelopment
- Recurrent middle ear infections and conductive hearing loss in childhood
- Delayed motor milestones, with walking typically starting at 18 to 24 months
- Dental crowding from smaller jaw size
Who gets Achondroplasia?
Achondroplasia is present from birth and affects males and females equally across all racial and ethnic groups. About 80% of cases are de novo mutations in parents of average height, with a strong association with advanced paternal age.
The remaining 20% are inherited from an affected parent in an autosomal dominant pattern. Average adult height is approximately 4 feet 4 inches for males and 4 feet 1 inch for females.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Achondroplasia?
There are currently 2 FDA-approved medications for Achondroplasia.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
Which new Achondroplasia medicines are in trials?
Investigational medicines Trial Friend tracks for Achondroplasia, with trial results, safety findings and where each one stands.
How to get help paying for Achondroplasia treatment
Charity funds and drugmaker programs for Achondroplasia, checked at the source.
- From a charity · Little People of AmericaGrant for Overall Accessible Living (GOAL) fundOpen
Pays for: Mobility devices and occupational tools (partial cost; LPA membership required).
The foundation says: “Applications are being accepted for the GOAL Fund.”
- Voxzogo (Vosoritide) · BioMarin RareConnections
- Yuviwel (Navepegritide) · Ascendis Signature Access Program (A.S.A.P)
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Achondroplasia
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Achondroplasia resources
Reputable organizations and medical references for learning more about Achondroplasia, including disease registries, foundation resources, and clinical guidelines.